Elevance Health Inc. (ELV)
NYSE: ELVHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ELV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $85.23B
- P/E (TTM)
- 16.75
- Forward P/E
- 13.02
- EPS (TTM)
- $23.55
- Dividend yield
- 1.74% ($6.87)
- Ex-dividend date
- Sep 10, 2026
- 52-week range
- 274.84 – 450.69
- Day range
- 393.55 – 406.36
- Volume / Avg
- 2.04M / 1.31M
- Beta
- —
- Shares outstanding
- 216.06M
52-week range
ELV stock today
Shares of Elevance Health (ELV) finished higher on Nov 20 at $394.48, a gain of 1.11% or $4.32 per share, versus the S&P 500's 3.70% decline. Shares are 12.5% below their 52-week high of $450.69, set on Oct 21, 2026 and 43.5% above the 52-week low of $274.84, in the middle of the past year's range. ELV is up 12.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 22.6%.
At 16.8x trailing earnings, Elevance Health trades below the peer-group median of 27.9x. Its forward P/E of 13.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Elevance Health pays an annual dividend of $6.87 per share, a 1.74% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Elevance Health
Company profileElevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Ms. Gail Koziara Boudreaux
- Headquarters
- Indianapolis, IN
- Employees
- 96,129
- Website
- elevancehealth.com
Financial highlights
Full financialsIn fiscal 2025, Elevance Health generated $199.13 billion in revenue, up 12.5% from fiscal 2024, its 15th consecutive year of revenue growth. Net income was $5.66 billion (-5.3% year over year), for a net margin of 2.8% versus a median of 3.8% in the prior 5 years. Gross margin was 89.4% (up from 88.8%) and operating margin 3.6%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $199.13B | $177.01B | $171.34B | $156.59B | $138.64B |
| Growth | +12.49% | +3.31% | +9.42% | +12.95% | +13.76% |
| Net income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B |
| EPS (diluted) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 |
Analyst forecast
ForecastConsensus (22 analysts)
buy
Avg. price target
$482.38+22.28%
- Strong buy 3
- Buy 12
- Hold 7
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 21, 2026
- EPS actual vs est.
- $6.27 vs $4.66
- Surprise
- +34.55%
Dividends
Dividend history- Annual dividend
- $6.87
- Dividend yield
- 1.74%
- Last payment
- $1.72
- Ex-dividend date
- Sep 10, 2026
ELV news
All ELV news- Stocks Meltdown as AI Trade UnravelsNasdaqGOOGL, AAPL, ANET, HRL
- Stocks Sink as Tech Rout DeepensNasdaqANET, HRL, SNDK, HL
- Global Stocks Retreat on Unwind of the AI TradeNasdaqANET, HRL, SNDK, HL
- Elevance Health (ELV) Down 12.4% Since Last Earnings Report: Can It Rebound?Nasdaq
- Stock Indices Plunge Amid Broad Market WeaknessNasdaqGOOGL, AAPL, ANET, SNDK
- Stocks Erase Early Gains as Anthropic Optimism FadesNasdaqCVS, BE, SNDK, UTI
- Stocks Climb on AI Optimism After Strong Debut for AnthropicNasdaqGOOGL, AAPL, ANET, SNDK
- Argus Research Upgrades Elevance Health to Buy from HoldNasdaq
Elevance Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CIThe Cigna Group | 270.90 | -0.78% | $71.38B | vs ELV |
| HUMHumana Inc. | 390.00 | +2.63% | $46.84B | vs ELV |
| NTRANatera Inc. | 273.40 | -5.70% | $39.64B | vs ELV |
| CNCCentene Corporation | 63.78 | -2.74% | $31.58B | vs ELV |
| LHLabcorp Holdings Inc. | 367.13 | -0.47% | $29.81B | vs ELV |
| ILMNIllumina Inc. | 192.82 | -3.90% | $29.15B | vs ELV |
| DGXQuest Diagnostics Incorporated | 258.28 | -0.31% | $28.42B | vs ELV |
| GHGuardant Health Inc. | 145.83 | +0.16% | $19.73B | vs ELV |
Indexes, lists and sector
Elevance Health stock FAQ
What is Elevance Health's stock price today?
ELV last traded at $394.48 as of Nov 20, 4:00 PM EST, up 1.11% on the day. Prices are delayed at least 15 minutes.
Does Elevance Health pay a dividend?
Yes. Elevance Health pays $6.87 per share annually, a 1.74% yield. The most recent dividend of $1.72 had an ex-dividend date of Sep 10, 2026.
What is ELV's P/E ratio?
ELV trades at a trailing P/E ratio of 16.75 and a forward P/E of 13.02, compared with a median of 27.9 for its closest peers.
Is Elevance Health in the S&P 500?
Yes. Elevance Health (ELV) is a constituent of the S&P 500 index.
Who is Elevance Health's CEO?
Ms. Gail Koziara Boudreaux is the chief executive officer of Elevance Health Inc., which has about 96,129 employees.
Has ELV ever split its stock?
Yes. The most recent ELV stock split was a 2-for-1 split on Jun 1, 2005.
What is the ELV 52-week high?
The 52-week high for ELV is $450.69 and the 52-week low is $274.84. The stock is currently 12.5% below its high.